MCLEAN, Va.

麦克莱恩，弗吉尼亚州

,

，

March 19, 2026

2026年3月19日

/PRNewswire/ --

/PRNewswire/ --

Clearsight Advisors, Inc.

明见顾问公司

('Clearsight') is pleased to announce another successful transaction in its Healthcare and Life Sciences Services practice. Clearsight served as the exclusive financial advisor to

（Clearsight）很高兴宣布其在医疗保健和生命科学服务领域的又一成功交易。Clearsight 担任了独家财务顾问，

Stratis Group, LLC

斯特拉蒂斯集团，有限责任公司

(the 'Company' or 'Stratis') in its acquisition by

（“公司”或“Stratis”）在其被收购过程中

Nexus Health

健康纽带

, part of

，部分

The Lockwood Group, LLC

洛克伍德集团，有限责任公司

('Lockwood'), a portfolio company of

('Lockwood')，是一家投资组合公司

Ares Management Corporation

阿瑞斯管理公司

('Ares').

('阿瑞斯')。

Continue Reading

继续阅读

Clearsight_Advises_Stratis Group_in_its_Acquisition_by_Nexus Health

Clearsight_Advises_Stratis集团_在其被Nexus Health收购的过程中

Stratis Group is a consulting firm specializing in commercialization strategy, market access, patient services, and analytics for pharmaceutical, biotechnology, and physician network clients. Founded in 2014, the Company brings a differentiated, data-driven approach to commercialization by combining advanced analytics, customer research, and market insights to inform strategy and optimize outcomes.

Stratis Group 是一家咨询公司，专注于为制药、生物技术和医生网络客户提供商业化战略、市场准入、患者服务和分析服务。公司成立于 2014 年，通过结合高级分析、客户研究和市场洞察来制定战略并优化结果，从而以差异化、数据驱动的方式推动商业化进程。

Stratis's service offerings include health economics and outcomes research (HEOR), real-world evidence generation, forecasting and epidemiology, patient support services, field reimbursement advisory and management, brand analytics, and market access optimization. Stratis supports innovators across the commercialization lifecycle by improving access, strengthening product positioning, and enhancing patient and provider engagement..

Stratis的服务项目包括卫生经济学和结果研究（HEOR）、真实世界证据生成、预测与流行病学、患者支持服务、现场报销咨询与管理、品牌分析以及市场准入优化。Stratis通过改善准入、强化产品定位以及提升患者和供应商的参与度，支持创新者贯穿整个商业化生命周期。

Nexus Health, part of The Lockwood Group, is a strategic consulting and market access firm that delivers integrated, data-driven commercialization solutions to life sciences organizations. Nexus has broadened its capabilities in recent years to include strategic consulting, value communications, and patient access and affordability solutions, complementing Lockwood's broader medical communications and commercialization services platform..

Nexus Health是The Lockwood Group的一部分，是一家战略咨询和市场准入公司，为生命科学组织提供集成的、数据驱动的商业化解决方案。近年来，Nexus拓展了其能力，涵盖战略咨询、价值沟通以及患者准入和可负担性解决方案，进一步完善了Lockwood更广泛的医学沟通和商业化服务平台。

Through this transaction, Stratis joins Nexus Health and enhances its ability to deliver integrated, data-driven commercialization and market access solutions at greater scale. The combination strengthens Stratis's capabilities across patient services, HEOR, real-world evidence generation, field reimbursement, and analytics, while complementing Nexus Health's medical affairs, commercialization, access, and oncology education offerings.

通过此次交易，Stratis 加入了 Nexus Health，并增强了其大规模提供集成化、数据驱动的商业化和市场准入解决方案的能力。这一组合加强了 Stratis 在患者服务、卫生经济学与结果研究 (HEOR)、真实世界证据生成、现场报销及分析方面的能力，同时补充了 Nexus Health 在医学事务、商业化、市场准入及肿瘤学教育方面的服务内容。

Together, Stratis and Nexus are positioned to support clients from early commercialization planning through launch and lifecycle optimization, expanding Stratis's impact and accelerating its growth as part of Lockwood's healthcare services platform..

Stratis 和 Nexus 共同致力于为客户提供从早期商业化规划到上市及生命周期优化的全程支持，扩大 Stratis 的影响力，并加速其作为 Lockwood 医疗服务平台一部分的增长。

Joseph Musumeci, Co-Founder at Stratis Group, commented on the transaction, 'Clearsight's team was a true partner from day one. They understood our market, brought thoughtful guidance to every stage of the process, and advocated for the outcome that best serves our clients and people. Their steady leadership and clear communication made a complex transaction feel manageable and well-executed.'.

斯特拉蒂斯集团的联合创始人约瑟夫·穆苏梅奇在谈到这笔交易时表示：“Clearsight 的团队从第一天起就是真正的合作伙伴。他们了解我们的市场，在整个过程的每个阶段都提供了深思熟虑的指导，并倡导最符合我们客户和员工利益的结果。他们稳定的领导和清晰的沟通使这一复杂的交易显得易于管理且执行得当。”

Tory Steel

托里·斯蒂尔

, Managing Director at Clearsight Advisors, noted, 'Stratis brings deep domain expertise and a pragmatic, data-driven approach to solving market access challenges. We are proud to have advised their team on this important milestone and excited to see Stratis extend its influence and accelerate growth as part of Lockwood's broader healthcare communications platform.'.

Clearsight Advisors董事总经理指出：“Stratis带来了深厚的领域专业知识和务实的、数据驱动的市场准入挑战解决方案。我们很荣幸能够为其团队提供这一重要里程碑的咨询服务，并期待看到Stratis作为Lockwood更广泛的医疗保健传播平台的一部分，扩大其影响力并加速增长。”

Austin Kuhn

奥斯汀·库恩

, Director at Clearsight Advisors, added 'Joe and Casey identified a pain-point in the pharma and biotech commercialization journey and built a tailored solution for it, resulting in the Company's explosive growth in recent years. It was fantastic working with such creative business leaders, and we feel privileged to have supported them in this transaction.'.

Clearsight Advisors的董事补充道：“乔和凯西发现了制药和生物技术商业化过程中的一个痛点，并为此构建了定制化的解决方案，从而推动了公司近年来的爆炸性增长。能与这样富有创意的商业领袖合作真是太棒了，我们很荣幸能够在此交易中支持他们。”

The Clearsight deal team included

Clearsight 交易团队包括

Tory Steel

托里·斯蒂尔

,

，

Greg Treger

格雷格·特雷格

,

，

Austin Kuhn

奥斯汀·克恩

,

，

Jake Kohlbrenner

杰克·科尔布伦纳

,

，

Miles Gally

迈尔斯·加利

, and

，以及

Brandon Curran

布兰登·柯伦

.

。

About Clearsight Advisors

关于 Clearsight 顾问公司

Clearsight Advisors is an investment banking firm dedicated to providing world-class M&A and capital-raising solutions to growth-oriented Business Services and Technology companies. Clearsight Advisors, Inc. is a wholly owned subsidiary of Regions Financial Corporation. No offerings of securities are made through this site; all securities are offered exclusively through RF M&A Services LLC and/or Regions Securities LLC, both are registered broker-dealers and members of .

Clearsight Advisors是一家投资银行，致力于为成长型商业服务和技术公司提供世界级的并购和融资解决方案。Clearsight Advisors, Inc. 是Regions Financial Corporation的全资子公司。本网站不提供证券发售；所有证券均由RF M&A Services LLC和/或Regions Securities LLC独家提供，这两家公司均为注册经纪交易商和成员。

FINRA

金融行业监管局

and

和

SIPC

证券投资者保护公司 (SIPC)

. Testimonials may not be representative of all client experiences. Testimonials are not a guarantee of future performance or success. Links to external sites are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Clearsight Advisors of any of the products, services or opinions of the corporation or organization or individual.

推荐信可能并不代表所有客户的体验。推荐信并非未来业绩或成功的保证。提供外部网站链接仅为方便起见，并用于信息目的；这些链接并不构成Clearsight Advisors对任何公司、组织或个人的产品、服务或意见的认可或批准。

Clearsight Advisors is not responsible for the accuracy or content of linked third-party websites. Also, please be aware that the security and privacy policies on these third-party sites may differ from our policies, so please read third-party privacy and security policies closely. For more information visit .

Clearsight Advisors 不对链接的第三方网站的内容或准确性负责。此外，请注意这些第三方网站的安全性和隐私政策可能与我们的政策不同，因此请仔细阅读第三方的隐私和安全政策。欲了解更多信息，请访问。

https://www.clearsightadvisors.com

https://www.clearsightadvisors.com

SOURCE Clearsight Advisors

来源：Clearsight Advisors

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示